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alla hepática aguda en una paciente con
índrome de DRESS que revirtió con
-acetilcisteína y prednisona. Reporte de caso
revisión de la literatura
rug Rash with Eosinophilia and Systemic Symptoms (DRESS)
s an idiosyncratic reaction to medication1 that is charac-
erized by skin rash, hematologic alterations, and organ
nvolvement.2 It has been related to the ingestion of pheny-
oin and other anticonvulsant agents.3 Skin reactions have
een described in up to 19% of patients between 6 and 8
eeks after drug initiation.3 The mortality rate is above
0% and death is commonly secondary to acute liver failure
ALF).4
One month before her hospital admittance, a 46-year-old
oman presented with subarachnoid hemorrhage due to a
uptured aneurysm of the posterior left cerebral artery; the
ffected vessel was clipped and she began adjuvant manage-
ent with 100mg of phenytoin every 8 h. She had no past
istory of herbal medicine or alcohol consumption, or prior
se of other medication or hepatotoxic agents. Forty-eight
ours after drug initiation, the patient noticed maculopapu-
ar lesions on both hands that resolved spontaneously, with
o other symptoms. Three weeks later the maculopapular
esions became generalized and turned into an exfoliative
ermatitis. She developed unmeasured fever along with pru-
itus, jaundice, and choluria. Upon hospital admittance the
atient presented with dehydration, jaundice, generalized
aculopapular lesions with ﬁne ﬂaking (ﬁg. 1), cervical ade-
omegaly, hepatomegaly of 3 cm under the costal margin,
albumin 2.9 g/L, alanine aminotransferase 171 U/L, aspar-
tate aminotransferase 333 U/L, alkaline phosphatase 751
U/L, gamma-glutamyl transpeptidase 1,814 U/L, prothrom-
bin time 38%, and international normalized ratio (INR) 1.8.
Cultures had no pathogen development, the viral panel was
negative for hepatitis A, B, and C, and cytomegalovirus
(CMV) and Epstein-Barr virus (EBV) IgM serology were nega-
tive. Abdominal ultrasound showed no chronic hepatopathy
data, no biliary tract dilation, no vascular thrombosis, and
no alterations in either kidney. Management was begun with
prednisone 1 g/kg of weight and pentoxifylline 300mg every
6 h; on her second day in the hospital, the patient presented
with stage 2 hepatic encephalopathy characterized by aster-
ixis and bradypsychia. The data indicated: stage 2 HE, INRnd no hepatic encephalopathy (HE). Her laboratory tests
eported: leukocytes 5,000 L--1, eosinophils 1,800 L--1, urea
04mg/dL, creatinine 5.6mg/dL, total bilirubin 8.6mg/dL,
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Digure 1 Cutaneous lesions characteristic of DRESS. A, A’)
pon admission. B) Progression after 4 days of treatment. C)
ay 6 of treatment.
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Table 1 Laboratory test progression at diagnosis, day 4,
and day 6.
Laboratory tests Treatment
initiation
Day 4 Day 6
Leukocytes (x10e3/uL) 5.0 8.2 11.7
Eosinophils (x10e3/uL) 1.8 0.9 1.17
Hemoglobin (g/dL) 10.1 9.8 9.2
Platelets 176000 199000 172000
Glucose (mg/dL) 81 115 88
Urea (mg/dL) 104 30 32.1
Creatinine (mg/dL) 5.6 1.3 1.1
Uric acid (mg/dL) 8.5 3.1
Total bilirubin (mg/dL) 8.6 9.2 9.6
Direct bilirubin (mg/dL) 5.6 5.6 5.9
Indirect bilirubin (mg/dL) 3.0 3.6 3.7
Albumin (g/dL) 2.9 2.1 1.8
ALT (U/L) 271 102 80
AST(U/L) 333 211 106
ALP (U/L) 751 567
GGT (U/L) 1814 987
LDH (U/L) 587 538
Na 124 150 147
K 4.9 2.6 3.7
CL 91 115 111
Ca 8.8 7.3
Phosphorus 3.9 2
Magnesium 2.3 1.6
PT (%) 38.9% 76%
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> 1.5 and a duration < 26 weeks in a patient without cir-
rhosis, corresponding to ALF; oral N-acetyl cysteine (NAC)
140mg/kg as a loading dose was added to her management,
continuing with 17 doses of 70mg/kg every 4 h, carrying out
the complete dose in 3 days. Vitamin K 20mg/day was also
administered. The maculopapular lesions decreased around
36 h after treatment initiation and the HE disappeared. Kid-
ney function and liver function tests improved (Table 1).
Within the ﬁrst month of progression, the maculopapular
lesions resolved after generalized ﬂaking, as did the jaun-
dice.
The exact incidence of DRESS syndrome is not known; it
is estimated at 1 for every 1,500 new users of phenytoin
and carbamazepine.3 Clinical symptoms are characterized
by fever preceding the appearance of maculopapular lesions
that advance to exfoliative dermatitis.3 The diagnostic crite-
ria of the disease were described by Bocquet in 1996:1,2,5,6
1) suspicion of adverse reaction to medications, 2) > 1,500
eosinophils and/or atypical lymphocytes, 3) 2 visceral dis-
orders: cutaneous, diffuse adenopathy > 2 cm, hepatitis (> 2
times the normal transaminase value), interstitial nephri-
tis, pneumonitis, pericarditis, myocarditis, thyroiditis, or
meningoencephalitis.
The differential diagnosis with other types of reactions to
medication should be made: Steven-Johnson syndrome and
toxic epidermal necrolysis,1 in addition to ruling out infec-
tious diseases (chicken pox, infectious mononucleosis) and
pathologies such as Kawasaki syndrome, hypereosinophilic
syndrome, and drug-induced pseudolymphoma.1209
Its pathophysiology is unknown, but it has been associ-
ted with immunologic factors and genetic predisposition.
etoxiﬁcation defects leading to the formation of reactive
etabolites, activated T lymphocytes that release cytokines
IFN- and IL-5), exerting cytotoxicity, have been proposed;7
thers have considered it to be a systemic reaction due to
eactivation of the human herpes virus 6 and 7, EBV, or
MV.1,5
The drugs most associated with the development of
RESS are the anti-epileptic agents (phenobarbital, car-
amazepine, phenytoin, sodium valproate, lamotrigine),
llopurinol, sulfasalazine, dapsone, and minocycline. Antibi-
tics or nonsteroidal anti-inﬂammatory analgesics have
arely been reported.2 The disorder is independent of the
uantity of the drug, having a greater relation to the sus-
eptibility of the individual.
The ﬁrst step of treatment is the deﬁnitive suspension of
he medication at fault. Local steroids and antihistamines
an be used in cases that are not severe. There are no crite-
ia for the systemic use of steroids, but they are generally
sed in patients with organ involvement.2,4 In cases of ALF,
doses of intravenous methylprednisolone at 1mg/kg of
eight, followed by oral steroid, has shown good results.7
Liver transplantation (LT) is the treatment of choice for
atients with ALF that do not respond to high doses of
teroids.8 NAC has been proposed as part of the treatment
or patients with ALF secondary to the ingestion of para-
etamol, as an antidote to intoxication by that drug, and
ome studies have shown its usefulness in patients with ALF
ue to the ingestion of other medications.9,10 NAC combined
ith steroids has been reported mainly in patients with
nticonvulsant-induced DRESS, with a favorable response,10
ut the number of studies supporting its use is insufﬁcient.9
Our patient’s illness was induced by phenytoin and upon
dmittance she showed data of ALF and acute renal failure
ARF) (probably due to interstitial nephritis). She was suc-
essfully treated with the combination of oral steroid and
AC and the suspension of phenytoin. We believe that early
nitiation of the double therapy in ALF patients can lead to
mprovement, averting the need for LT.
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